Completed PHASE3 INTERVENTIONAL NCT00209573

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy

A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN Injection Versus Midazolam HCl for Sedation in Patients Undergoing Colonoscopy Procedures

Sponsor: Bio Analytical Research Corporation

Conditions Colon Polyps Colonoscopy

Interventions fospropofol disodium

Updated 8 times since 2017 Last updated: Nov 6, 2008 Started: Sep 30, 2004 Completion: Dec 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00209573, this PHASE3 trial focuses on Colon Polyps and Colonoscopy and remains completed. Sponsored by Bio Analytical Research Corporation, it has been updated 8 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE3
Oct 2024 — Jun 2025 [monthly]

Completed PHASE3
Sep 2024 — Oct 2024 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bio Analytical Research Corporation
Coghlan Group (Plasma Sample Supplies)
Eisai Inc.
MDS Pharma Services
PPD Development, LP

Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.